Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis

Cited by (333)

Items 101–200 of 333

1. Is hepatocellular carcinoma surveillance in high-risk populations effective?
   Kristeen Onyirioha, Sukul Mittal, Amit G. Singal · 2020 · Hepatic Oncology
2. ‘We can bear it!’ Unpacking barriers to hepatocellular carcinoma screening among patients with hepatitis B: A qualitative study
   Caixia Li, Xiling Lu, Jinnan Xiao, Carmen W.H. Chan · 2021 · Journal of Clinical Nursing
3. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC)
   Jinna Chu, George T. Cholankeril, Xian Yu, Abbas A. Rana, Yamini Natarajan, Hashem B. El‐Serag, Jennifer R. Kramer, Fasiha Kanwal · 2022 · Digestive Diseases and Sciences
4. Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice
   Melisa Dirchwolf, Sebastián Marciano, Andrés Eduardo Ruf, Amit G. Singal, Vanina D'Ercole, Paola Coisson, Alina Raquel Zerega, Federico Orozco, Ana Palazzo, E Fassio et al. · 2021 · Annals of Hepatology
5. Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study
   Jeffrey Victor Lazarus, Leire Agirre‐Garrido, Trenton M. White, Anish Kumar Arora, Melina I. Manolas, Luis Antonio Díaz, Juan Pablo Arab, Shira Zelber‐Sagi, Naim Alkhouri, C Wendy Spearman et al. · 2025 · The Lancet. Gastroenterology & hepatology
6. Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
   Â. Mattos, J. Debes, R. Dhanasekaran, J. Benhammou, M. Arrese, André Luiz V. Patrício, A. C. Zilio, Angelo A. Mattos · 2021 · World Journal of Hepatology
7. Correlation of LI-RADS 3 or 4 Observations with Histopathologic Diagnosis in Patients with Cirrhosis
   Colin T. Dunn, Bo Lin, Nicole E. Rich, Madhukar S. Patel, Purva Gopal, Amit G. Singal · 2022 · Clinical Gastroenterology and Hepatology
8. Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma
   Lauren Tal Grinspan, Augusto Villanueva · 2022 · Seminars in Liver Disease
9. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
   Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin Paul Canakis, Mohammad Bourmaf, Cyrus Adams‐Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty · 2023 · International Journal of Molecular Sciences
10. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis
    Mohamed Salaheldin, Heba Ismail Saad Aly, Louis Ho Shing Lau, Shimaa Afify, Mohamed El‐Kassas · 2023 · Diagnostics
11. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography
    Mădălina-Gabriela Țâru, Monica Lupșor‐Platon · 2023 · Cancers
12. Surveillance for Hepatocellular Carcinoma
    Jorge A. Marrero · 2020 · Clinics in Liver Disease
13. Outcome of Hepatocellular Carcinoma Detected During Surveillance: Comparing USA and Japan
    Hidenori Toyoda, Atsushi Hiraoka, Jocelyn Olivares, Taim Al-Jarrah, Pauline Devlin, Yuji Kaneoka, Atsuyuki Maeda, Adam Charles Yopp, Neehar D. Parikh, Amit G. Singal · 2020 · Clinical Gastroenterology and Hepatology
14. Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement
    Josep Maria Llovet, Ezequiel Mauro, Lorenza Rimassa, Vincenzo Mazzaferro, Matthias Pinter, Robin Kate Kelley, Stephen Lam Chan, Laura Kulik, Anjana A Pillai, Lewis Rowland Roberts et al. · 2026 · Nature Reviews Clinical Oncology
15. Impact of racial, ethnic, and socioeconomic disparities on presentation and survival of HCC: A multicenter study
    Nicole E. Rich, Patricia Denise Jones, Hong Zhu, Tanushree Prasad, Amy E. Hughes, Sandi L. Pruitt, Caitlin C. Murphy, Karim Seif El Dahan, Darine Daher, Gloria Figueroa et al. · 2024 · Hepatology Communications
16. Impact of social determinants of health on hepatocellular carcinoma surveillance, treatment, and health care costs
    Amit G. Singal, Karl M. Kilgore, Elizabet Shvets, Neehar D. Parikh, Neil J. Mehta, Ahmet Burak Ozbay, Christie L. Teigland, Omar Hafez, Amy L. Schroeder, Audrey Yang et al. · 2024 · Hepatology Communications
17. Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening
    Nicole J. Kim, Muyi Li, Philip Vutien, Brig Mecham, Joleen A. Borgerding, Kayta Swarts, Pranusha Atuluru, Martha Michel, Abbey Barnard Giustini, Catherine Mezzacappa et al. · 2025 · Gastroenterology
18. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis
    Nikita Sandeep Wagle, Sulki Park, David J. Washburn, Robert L. Ohsfeldt, Hye‐Chung Kum, Amit G. Singal · 2024 · Cancer Epidemiology Biomarkers & Prevention
19. Associations of tumor-related psychiatric symptoms and healthy behaviors with dynamic quality of life after hepatocellular carcinoma hepatectomy
    Feng-Juan Zhao, Rong‐Rui Huo, Fan-Rong Li, Xue-Mei You · 2024 · Supportive Care in Cancer
20. Benefits and harms of hepatocellular carcinoma screening outreach in patients with cirrhosis: a multicenter randomized clinical trial
    Amit G. Singal, Darine Daher, Manasa Narasimman, Sruthi Yekkaluri, Yan Liu, Vanessa Cerda, Chaitra Banala, Aisha Khan, MinJae Lee, Karim Seif El Dahan et al. · 2024 · JNCI Journal of the National Cancer Institute
21. Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic
    Hiroyuki Suzuki, Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert, Raymond T. Chung, Takumi Kawaguchi, Yujin Hoshida · 2025 · Hepatology
22. Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
    Manon Allaire, Leonardo Gomes da Fonseca, Marco Sanduzzi‐Zamparelli, Won‐Mook Choi, Cecilia Monge, Ken Liu, Michael Leibfried, Sarah Manes, Zorana Maravic, Milan Mishkovikj et al. · 2025 · The Lancet Regional Health - Europe
23. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom
    Osvaldo Ulises Garay, LE Ambühl, Thomas Graham Bird, Eleanor J. Barnes, William Lucien Irving, Ryan Walkley, Ian A.C. Rowe · 2024 · Value in Health
24. Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey
    Tongluk Teerasarntipan, Yingluk Sritunyarat, Parinda Prathyajuta, Palada Pitakkitnukun, Chonlada Phathong, Darlene Ariyaskul, Kittipat Kulkraisri, Pisit Tangkijvanich, Sombat Treeprasertsuk, Rungsun Rerknimitr et al. · 2022 · Medicine
25. Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma
    Hidenori Toyoda, Mounika Kanneganti, Jonathan Melendez-Torres, Neehar D. Parikh, Prasun K. Jalal, Federico Piñero, Manuel Mendizábal, Ezequiel Ridruejo, Hugo Cheinquer, Andrea Casadei Gardini et al. · 2023 · Clinical Gastroenterology and Hepatology
26. Analysis of Serum Exosome Metabolites Identifies Potential Biomarkers for Human Hepatocellular Carcinoma
    Tingting Zhao, Yan Liang, Xiaolan Zhen, Hong Wang, Song Li, Didi Xing, Hui Li · 2024 · Metabolites
27. Evolving epidemiology of HCC in Spain
    Margarita Sala, Sonia Pascual, Maria Rosa Rota Roca, Ana María Matilla, Marta Campos, Manuel B. Delgado, María Teresa Ferrer, J.L. Montero, Jesús Manuel González Santiago, Antonio F. Guerrero et al. · 2025 · JHEP Reports
28. Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis
    Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Elena-Daniela Grigorescu, Adina-Bianca Foșălău, Alina Onofriescu, Bogdan Mircea Mihai · 2025 · Journal of Clinical Medicine
29. Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinoma
    Karim Seif El Dahan, Takeshi Yokoo, Darine Daher, Matthew S. Davenport, David T. Fetzer, Mishal Mendiratta‐Lala, Nicole E. Rich, Edward Yang, Neehar D. Parikh, Amit G. Singal · 2025 · JHEP Reports
30. Impact of age on clinical outcomes among patients with hepatocellular carcinoma: A systematic review and meta-analysis
    Olgert Bardhi, Darine Daher, Mausam J. Patel, Karim Seif El Dahan, Nicole E. Rich, Sukul Mitta, Neehar D. Parikh, Anjana A Pillai, Laura Kulik, Ju Dong Yang et al. · 2025 · JHEP Reports
31. Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study
    Amit G. Singal, Ju Dong Yang, Prasun K. Jalal, Reena J. Salgia, Neil J. Mehta, Maarouf A. Hoteit, Karissa Kao, Darine Daher, Karim Seif El Dahan, Perla Hernandez et al. · 2025 · The American Journal of Gastroenterology
32. AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review
    Nicole E. Rich, Augusto Villanueva, Jorge A. Marrero, Fasiha Kanwal · 2026 · Gastroenterology
33. Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis
    Mohammad Azharul Karim, Amit G. Singal, Hye‐Chung Kum, Yi‐Te Lee, Sulki Park, Nicole E. Rich, Mazen Noureddin, Ju Dong Yang · 2023 · Cancer Research Communications
34. How nurses contribute to the elimination of hepatitis B? A systematic review and meta-analysis.
    Cai-Xia Li, Meng-Xing Zhang, K. Karthijekan, Xia Fu · 2023 · International Journal of Nursing Studies
35. A randomized trial of mailed outreach with behavioral economic interventions to improve liver cancer surveillance
    Shivan J. Mehta, Caitlin McDonald, Catherine Reitz, Shivani Kastuar, Christopher K. Snider, Evelyn Okorie, Kiernan McNelis, Hamzah Shaikh, Tessa Sundaram Cook, David Seth Goldberg et al. · 2023 · Hepatology Communications
36. Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
    Mindie H. Nguyen, Lewis Rowland Roberts, Nicole M. Engel-Nitz, Tim Bancroft, Ahmet Burak Ozbay, Amit G. Singal · 2022 · Hepatology Communications
37. Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
    Yi‐Te Lee, Mohammad Azharul Karim, Hye‐Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang · 2023 · Clinical and Molecular Hepatology
38. Hepatocellular carcinoma screening in NAFLD: The paradox of nearly half the cases arising in non-cirrhotic low risk patients
    Mariana Verdelho Machado · 2023 · Annals of Hepatology
39. Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis
    Somaya A. M. Albhaisi, Jing Sun, Arun Jayant Sanyal · 2023 · Frontiers in Oncology
40. Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis
    Amit G. Singal, Jagpreet Chhatwal, Neehar D. Parikh, Elliot B. Tapper · 2024 · Liver Cancer
41. Older Age But Not Comorbidity Is Associated With Worse Survival in Patients With Hepatocellular Carcinoma
    Mounika Kanneganti, Mohammed Al-Hasan, Samantha Bourque, Sneha Deodhar, Ju Dong Yang, Daniel Q. Huang, Anand V. Kulkarni, Purva Gopal, Neehar D. Parikh, Fasiha Kanwal et al. · 2024 · Clinical Gastroenterology and Hepatology
42. Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients
    Elizabeth S. L. Low, Ross Apostolov, Darren J Wong, Sandra Y. Lin, Numan Kutaiba, Josephine Grace, Marie J. Sinclair · 2021 · World Journal of Gastrointestinal Oncology
43. Psychiatric disorders in patients with hepatocellular carcinoma: A large US cohort of commercially insured individuals
    Mausam J. Patel, Alex R. Jones, Yue Jiang, Prajwal Gowda, Lisa B. VanWagner, Thomas G. Cotter, Karim Seif El Dahan, Jeremy Louissaint, Madhukar S. Patel, Nicole E. Rich et al. · 2024 · Alimentary Pharmacology & Therapeutics
44. Development of a nurse-led decision counseling program for improving hepatocellular carcinoma screening: A typology-guided feasibility study
    Caixia Li, Xiling Lu, Fei Gao, Eunice Lee, Carmen W.H. Chan · 2023 · Asia-Pacific Journal of Oncology Nursing
45. Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United States
    Jeff Liang, Yi‐Te Lee, Yee Hui Yeo, Michael Luu, Walid S. Ayoub, Alexander Kuo, Hirsh D. Trivedi, Aarshi Vipani, Srinivas Gaddam, Hyunseok Kim et al. · 2024 · Clinical and Translational Gastroenterology
46. Significant Disparities in Hepatocellular Carcinoma Outcomes by Race/Ethnicity and Sociodemographic Factors
    Shyam A. Patel, Mandana Khalili, Amit G. Singal, Paulo Sérgio Pinheiro, Patricia Denise Jones, Rebecca G. Kim, Vishwajit Kode, Anna Thiemann, Wei Zhang, Ramsey C Cheung et al. · 2024 · Cancer Epidemiology Biomarkers & Prevention
47. Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis
    Ryan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, Ethan Kai Jun Tham, Alfred Wei Chieh Kow, Guoyue Lv, Zhongqi Fan, Nicholas L. X. Syn, Masahito Nakano, Wenhao Li et al. · 2025 · Clinical Gastroenterology and Hepatology
48. A multi-analyte cfDNA-based blood test for early detection of hepatocellular carcinoma
    David J. Taggart, Shivani Mahajan, Maxime A. Gallant, Itai Pinkoviezky, Jianfeng Xu, Allison J. Sorg, Curt C. Roberts, Dmitri Slinkov, Emmanuel Cruz Gorospe, Abdullah Mubarak et al. · 2026 · Journal of Hepatology
49. Liver cancer risk quantification through an artificial neural network based on personal health data
    Afrouz Ataei, Jun Deng, Wazir Muhammad · 2023 · Acta Oncologica
50. Hepatocellular Carcinoma Surveillance
    Eden Koo, Amit G. Singal · 2023 · Surgical Oncology Clinics of North America
51. Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models
    Philip J. Johnson, Ehsan Bhatti, Hidenori Toyoda, Shan He · 2024 · JCO Clinical Cancer Informatics
52. DETECT: Development of Technologies for Early HCC Detection
    Jihane N. Benhammou, Nicole E. Rich, George T. Cholankeril, Peng Zhang, Weihua Zeng, Shuyun Rao, Nabihah Tayob, Wenyuan Li, Xiaoli Wu, Shuo Feng et al. · 2022 · Gastroenterology
53. Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
    Hamish A. Innes, Victoria Hamill, Scott McDonald, Peter Clive Hayes, Philip James Johnson, John Francis Dillon, Jen Bishop, Alan Yeung, April Went, Stephen T. Barclay et al. · 2022 · The American Journal of Gastroenterology
54. The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance
    Mishal Mendiratta‐Lala, David T. Fetzer, Aya Kamaya, Neehar D. Parikh, Amit G. Singal · 2024 · Radiology
55. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference
    Hashem B. El‐Serag, John W. Ward, Sumeet K. Asrani, Amit G. Singal, Nicole E. Rich, Aaron P. Thrift, Salil Deshpande, Barbara J. Turner, Ahmed Omar Kaseb, Ariel C. Harrison et al. · 2023 · Clinical Gastroenterology and Hepatology
56. Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review
    Christopher Mysko, Stephanie Landi, Huw Purssell, Alex J. Allen, Martin Prince, Gary Lindsay, Steven Rodrigues, Jenny Irvine, Oliver Street, Deepankar Gahloth et al. · 2025 · BJC Reports
57. Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study
    Juan Vaz, Hannes Hagström, Malin Sternby Eilard, Magnus Rizell, Ulf Strömberg · 2025 · The Lancet Regional Health - Europe
58. Performance of the multi-target hepatocellular carcinoma blood test: Design and rationale of the ALTUS study
    Binu V. John, Mark Camardo, Kyle M. Porter, Paul Z. Elias, Elle Kielar‐Grevstad, Seema P. Rego, Neehar D. Parikh, Lewis Rowland Roberts, Alvin C. Silva, Amit G. Singal et al. · 2025 · Hepatology Communications
59. PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort Study
    Huang Dj, Zhongjie Zhang, Rajkumar Dorajoo, Chiea Chuen Khor, Yen Thi‐Hai Pham, Renwei Wang, Jaideep Behari, Jian‐Min Yuan, Woon‐Puay Koh, Hung Nguyen Luu · 2026 · Alimentary Pharmacology & Therapeutics
60. Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making
    Hamish A. Innes, Philip James Johnson, Scott McDonald, Victoria Hamill, Alan Yeung, John Francis Dillon, Peter Clive Hayes, April Went, Stephen T. Barclay, Andrew G. Fraser et al. · 2022 · Gastro Hep Advances
61. Redefining HCC Surveillance in India: A Call for Innovative and Inclusive Strategies
    Amit Yelsangikar, Prachi S. Patil · 2024 · Journal of Clinical and Experimental Hepatology
62. Comparison of the GALAD, GAAP, and ASAP Scores for Hepatocellular Carcinoma Detection in Patients With Chronic Liver Diseases
    Kessarin Thanapirom, Sirinporn Suksawatamnuay, Panarat M. Thaimai, Nipaporn Siripon, Nopavut Geratikornsupuk, Sombat Treeprasertsuk, Piyawat Komolmit · 2025 · Journal of Clinical and Experimental Hepatology
63. Surveillance for hepatocellular carcinoma at the community level: Easier said than done
    P. Del Poggio, Marzio Mazzoleni, Sergio Lazzaroni, A. D’Alessio · 2021 · World Journal of Gastroenterology
64. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
    Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, Lewis Rowland Roberts, Mindie H. Nguyen, Ahmet Burak Ozbay, Turgay Ayer, Neehar D. Parikh, Amit G. Singal · 2023 · Hepatology Communications
65. Surveillance for Hepatocellular Carcinoma in Cirrhosis: End of Monopoly for Serum Alpha Fetoprotein
    Lung‐Yi Mak, Man‐Fung Yuen · 2024 · Gastroenterology
66. Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
    Han Ah Lee · 2024 · Ewha Medical Journal
67. Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis
    Kornelius Schulze, Tim Daniel Rose, Lorenz Adlung, Manuela Peschka, Francesca Pagani, Joao Gorgulho, Thorben Fründt, Ismaïl Labgaa, Philipp Konstantin Haber, Carolin Zimpel et al. · 2025 · JHEP Reports
68. Effectiveness of a nurse-led decision counselling programme on hepatocellular carcinoma screening uptake among patients with hepatitis B: A randomised controlled trial
    Caixia Li, Xiling Lu, Juan Xu, Fei Gao, Eunice Y. Lee, Carmen W.H. Chan · 2023 · International Journal of Nursing Studies
69. Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease
    Feng-Pai Tsai, Tung‐Hung Su, Shang‐Chin Huang, Tai‐Chung Tseng, Shih–Jer Hsu, Sih‐Han Liao, Chun‐Ming Hong, Chen‐Hua Liu, Hung‐Chih Yang, Chun‐Jen Liu et al. · 2024 · Cancer
70. Risk of Hepatocellular Carcinoma in Subcentimeter Liver Nodules Identified on Surveillance Ultrasound: A Systematic Review
    Eden Koo, Karim Seif El Dahan, Darine Daher, Nicole E. Rich, Sukul Mittal, Ju Dong Yang, Neehar D. Parikh, Amit G. Singal · 2024 · Clinical Gastroenterology and Hepatology
71. Persisting challenges in the early detection of hepatocellular carcinoma
    Ashwini Arvind, K. Redmon, Amit G. Singal · 2025 · Expert Review of Anticancer Therapy
72. Moving Away From a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance
    Andrew M. Moon, George N. Ioannou · 2022 · The American Journal of Gastroenterology
73. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
    George T. Cholankeril, Hashem B. El‐Serag · 2022 · Seminars in Liver Disease
74. The Growing Landscape of NAFLD-Associated Hepatocellular Carcinoma and Its Impact in Surveillance
    Mariana Verdelho Machado · 2023 · GE Portuguese Journal of Gastroenterology
75. Extracellular vesicle‑mediated RNA editing may underlie the heterogeneity and spread of hepatocellular carcinoma in human tissue and in vitro
    Chikako Shibata, Motoyuki Otsuka, Takayuki Shimizu, Takahiro Seimiya, Takahiro Kishikawa, Taku Aoki, Mitsuhiro Fujishiro · 2023 · Oncology Reports
76. Blood-Based Biomarkers for HCC Surveillance: Ready for the Center Stage?
    Amit G. Singal, Ju Dong Yang, Neehar D. Parikh · 2023 · The American Journal of Gastroenterology
77. Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study
    Amit G. Singal, Neehar D. Parikh, Kirti Shetty, Steven‐Huy B. Han, Cassie Xie, Jing Ning, Jo Ann Rinaudo, Ashwini Arvind, Anna Suk-Fong Lok, Fasiha Kanwal et al. · 2024 · The American Journal of Gastroenterology
78. Blood Magnesium Level and Risk of Hepatocellular Carcinoma in a Prospective Liver Cirrhosis Cohort
    Xinyuan Zhang, Longgang Zhao, Qi Dai, Tao Hou, Christopher J. Danford, Michelle Lai, Xuehong Zhang · 2024 · Cancer Epidemiology Biomarkers & Prevention
79. Factors associated with nonadherence to surveillance for hepatocellular carcinoma among patients with hepatic C virus cirrhosis, 2000–2015
    Shen‐Shong Chang, Hsiao‐Yun Hu, Feng-Shiang Cheng, Yu-Chin Chen, Yung‐Feng Yen, Nicole Huang · 2022 · Medicine
80. Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma
    Timothy M. Block, Daniel Zezulinski, David Edward Kaplan, Jingqiao Lü, Samantha Zanine, Tingting Zhan, Cataldo Doria, Aejaz Sayeed · 2022 · Frontiers in Oncology
81. Letter to the Editor: Hepatocellular Carcinoma Surveillance in Cirrhosis Patients: Is the Real‐World Situation Even Worse Than Reported?
    Daniel Q. Huang, Yee Hui Yeo, Mindie H. Nguyen · 2021 · Hepatology
82. Early detection of primary liver cancer using plasma cell‐free DNA fragmentomics: Do all the pieces come together?
    Vatche Garen Agopian, Ju Dong Yang, Yazhen Zhu, Sungyong You, Hsian‐Rong Tseng · 2022 · Hepatology
83. Early screening for liver cancer must be performed
    Zihan Liu, Wenjun Wang, Shuangsuo Dang · 2025 · World Journal of Hepatology
84. Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi Panel
    Amit G. Singal, Hidenori Toyoda, Tawesak Tanwandee, Pisit Tangkijvanich, Chee‐Kiat Tan, Ian Homer Cua, Diana Alcantara‐Payawal, Tung‐Hung Su, Nguyen Dinh Song Huy, Hiroyuki Yamada et al. · 2025 · Liver Cancer
85. Synthesising enablers and barriers to hepatocellular carcinoma surveillance—A systematic review of qualitative findings
    Dina Moussa, Joan Ericka Flores, Joseph Doyle, Marno Celeste Ryan, Jack E. Wallace, Jessica A. Howell · 2025 · PLoS ONE
86. Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis at US Safety-Net Health Systems
    Robert J. Wong, Patricia Denise Jones, Bolin Niu, Paulo Sérgio Pinheiro, Mae Thamer, Onkar S. Kshirsagar, Yi Zhang, Ronnie Fass, George Therapondos, Amit G. Singal et al. · 2025 · Clinical and Translational Gastroenterology
87. Hepatocellular carcinoma: new insights into prevention and surveillance
    Mohammad Jarrah, Samantha Bourque, Ashok Kumar Choudhury, Amit G. Singal · 2025 · Expert Review of Gastroenterology & Hepatology
88. The versatile interplay between steatotic liver disease and liver cancer
    M. Rahbari, A. Gris-Oliver, P. Ramadori, David Aicher, D. Sia, Nisar Malek, R. Loomba, Ramón Bataller, J. Llovet, Mathias F. Heikenwälder · 2026 · Nature Reviews. Cancer
89. Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
    Manon Allaire, Tamar Hamosh Taddei, Dominique Thabut, Guadalupe García–Tsao · 2026 · Nature Reviews Gastroenterology & Hepatology
90. Novel Blood-Based Biomarkers for HCC
    Suraj Pai, Neehar D. Parikh · 2024 · Current Hepatology Reports
91. A meta-path, attention-based deep learning method to support hepatitis carcinoma predictions for improved cirrhosis patient management
    Zejian Wu, Da Xu, Paul Jen‐Hwa Hu, Li Liang, Ting Huang · 2024 · Decision Support Systems
92. A care coordination program to support patients with hepatitis B virus at Kaiser Permanente Mid-Atlantic States
    M. Cabell Jonas, Yi-Shin Sheu, Kara B Wright, Lauren Peyton, R. Clayton Bishop, Sundeep S. Basra, Fariha Sarwar, Grace Winn, Karen Chesbrough · 2024 · BMC Health Services Research
93. Dedicated Automatic Recall Hepatocellular Cancer Surveillance Programme Demonstrates High Retention: A Population‐Based Cohort Study
    Mayur Brahmania, Stephen E. Congly, Yashasavi Sachar, Kelly W. Burak, Brendan Cord Lethebe, Jessie M. H. Szostakiwskyj, David Lautner, Alexandra Medellin, Deepak Bhayana, Jason Wong et al. · 2025 · Liver International
94. Causes of mortality among patients with early-stage hepatocellular carcinoma
    Karim Seif El Dahan, Darine Daher, Nicole E. Rich, Anish Nayak, Caroline Ankoma-Sey, Rajalakshmi Govalan, Megha B. Bhongade, Emily Molina, Eunice Amador, Hannah Pitts et al. · 2025 · Hepatology
95. Cross-cultural adaptation and validation of a Chinese Preventive Health Model instrument for measuring the psychosocial factors in hepatocellular carcinoma screening among patients with hepatitis B
    Caixia Li, Xiling Lu, Cho Lee Wong, Fei Gao, Carmen W.H. Chan · 2022 · Asian Nursing Research
96. An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
    Robert J. Wong, Channa R. Jayasekera, Patricia Denise Jones, Fasiha Kanwal, Amit G. Singal, Aijaz Ahmed, Robert Taglienti, Zobair M. Younossi, Laura Kulik, Neil J. Mehta · 2022 · Gastroenterology Research
97. Development and Implementation of a Hepatocellular Carcinoma Surveillance Quality Metric
    Neehar D. Parikh, Cheryl L. Rhodes Dehmlow, Tammy Ellies, Elliot B. Tapper, Anna Suk-Fong Lok · 2022 · Clinical Gastroenterology and Hepatology
98. Anabolic deficits and divergent unfolded protein response underlie skeletal and cardiac muscle growth impairments in the Yoshida hepatoma tumor model of cancer cachexia
    D. Belcher, Nina Kim, Blanca Navarro-Llinas, M. Moller, F. López-Soriano, S. Busquets, Gustavo A. Nader · 2024 · Physiological Reports
99. Novel Therapeutics for Hepatocellular Carcinoma
    Mohamed I. Elsaid, Ashish Manne · 2025 · Clinics in Liver Disease
100. Racial and Ethnic Disparities in Survival among Patients with Cholangiocarcinoma in the United States: A Systematic Review and Meta-analysis
     Andrew D. Shubin, Phillip J. Leff, Meena M. Tadros, Meng‐Lun Hsieh, David Hsiehchen, Parsia A. Vagefi, Jason Y. Wang, Gonzalo Sapisochín, Adam Charles Yopp, Nina Niu Sanford et al. · 2025 · Cancer Epidemiology Biomarkers & Prevention